UbiquiTx is a startup based in the United States, 1 tracked investor.
UbiquiTx is a company headquartered in the United States. Brouky records 1 investor associated with the company.
UbiquiTx develops AI-driven proteome editing therapies by integrating deep learning, computational biology, and biological automation to design targeted protein degraders for regenerative medicine and treatment of diseases through precise modulation of protein interactions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.